Clinical trials
End Stage Liver DIsease clinical trials
Below are recruiting end stage liver disease clinical trials, each written for real people, not researchers. We’re tracking 83 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06367205Recruiting
Fluid and blood pressure management in kidney transplant
This trial tests a way to manage fluids and blood pressure during kidney transplant surgery to see if it improves recovery. It may be an option for people getting a kidney from a deceased donor.
Zhengzhou, HenanAges 18 years+ - NCT06408077Recruiting
How sodium levels are managed in kidney failure
This study looks at how the body handles salt (sodium) in people with end-stage kidney disease who are on dialysis. If you join, researchers will test how your body responds to changes in fluids and salt levels.
CologneAges 18 years+ - NCT06597201RecruitingPhase 4
Testing Amino Acid Dialysis Solution for Malnutrition on Peritoneal Dialysis
This trial tests a special peritoneal dialysis solution with amino acids (protein building blocks) to improve nutrition in people on CAPD who are malnourished. It might help boost your protein levels and overall health.
Hefei, AnhuiAges 18–75 - NCT06861816Recruiting
Walking with dogs for teens on dialysis
This study looks at whether a program of walking with dogs can help teenagers on dialysis breathe easier and feel less tired. It focuses on how the program might improve your lungs and your ability to be active.
Dokki, Giza GovernorateAges 13–17 - NCT06878560RecruitingPhase 1/Phase 2
Pig kidney transplant for kidney failure patients
This trial tests a special pig kidney (10 GE Xenokidney) as a transplant option for people with kidney failure who cannot get a human kidney. It aims to offer a life-saving alternative.
Chicago, IllinoisAges 40–70 - NCT07216885Recruiting
Testing a new hemodialysis machine in a dialysis center
This study tests a new dialysis machine called the Solv Multi-Pass System in a dialysis center. It looks at whether the machine works safely and effectively for people with end-stage kidney disease who need regular hemodialysis.
Greenville, South CarolinaAges 18 years+ - NCT07224763RecruitingPhase 1/Phase 2
Pig kidney transplant trial for kidney failure patients
This trial tests a genetically modified pig kidney (Thymokidney) for people with end-stage kidney disease who are on dialysis. It aims to see if this new type of transplant is safe and effective for those who cannot get a human kidney.
New York, New YorkAges 40–70 - NCT07291154Recruiting
Using an app to improve dialysis quality
This trial tests if a smartphone app (via WeChat) can help people on dialysis better manage their treatment and improve quality of care. It's for adults who have been on regular dialysis for at least 3 months.
Chongqing, Chongqing MunicipalityAges 18–75 - NCT07370441Enrolling by invitationPhase 4
Amino acid dialysis fluid for better nutrition
This trial tests a special dialysis fluid with amino acids (building blocks of protein) to see if it helps improve nutrition in people on peritoneal dialysis who have low protein levels. If you qualify, it may help boost your nutrition.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT06494631Enrolling by invitation
New Graft for Dialysis Access in Kidney Failure
This study tests a new type of graft (aXess) for dialysis access in people with kidney failure who cannot get a fistula. The graft is placed in the arm to help with blood flow during dialysis.
Phoenix, ArizonaAges 18 years+ - NCT06406140Enrolling by invitationPhase 2/Phase 3
Niacin for cholesterol and phosphate in dialysis patients
This study tests whether a vitamin called niacin can help lower a type of cholesterol (Lp(a)) and reduce high phosphate levels in people on hemodialysis. It may offer a new way to improve heart and bone health for dialysis patients.
CairoAges 18 years+ - NCT04477967Recruiting
Creating a liver transplant biobank for children
This trial sets up a long-term collection of medical information and samples from children who have had a liver transplant. It helps doctors study outcomes over time and improve care for future patients.
Chongqing, Chongqing MunicipalityAges 1 month–18 years - NCT06871111RecruitingPhase 1
Bacteria treatment study for liver disease patients
This trial tests whether giving a mixture of helpful bacteria can improve gut health in people hospitalized with serious liver problems. It aims to see if restoring these bacteria can help with recovery.
Chicago, IllinoisAges 18 years+ - NCT07128797RecruitingPhase 1
Safety and tolerability of B1344 injections for NAFLD
This trial tests whether multiple injections of B1344 are safe and tolerable in people with nonalcoholic fatty liver disease (NAFLD). It aims to find the right dose and check how the drug works in the body.
Beijing, Beijing MunicipalityAges 18–75 - NCT07308548RecruitingPhase 2
Testing HP515 for fatty liver disease (NASH/MASH)
This trial tests a new drug called HP515 for people with non-alcoholic fatty liver disease, including NASH or MASH. It aims to see if the drug can help reduce liver fat and improve liver health.
Beijing, Beijing MunicipalityAges 18–65 - NCT05899231Recruiting
Online strengthening program while you wait for a liver transplant
This trial tests an online prehabilitation program (strength and fitness training delivered digitally) to help people who are likely to need a liver transplant become stronger before transplant. It may benefit people who feel “frail” or “pre-frail,” since improving strength before surgery can help recovery.
Calgary, AlbertaAges 18 years+ - NCT07248371Recruiting
Validating multi-omics for metabolic syndrome diseases
This study is testing a new way to look at health information (multi-omics) to better understand conditions related to metabolic syndrome, like diabetes or heart disease. It may help doctors find more personalized treatments.
TaoyuanAges 20 years+ - NCT06836609RecruitingPhase 1/Phase 2
Study of a new drug for fatty liver disease (MASLD/MASH)
This study tests a new drug called ALN-CIDEB for people with fatty liver disease (MASLD or MASH). The goal is to see if it can reduce liver fat and improve liver health. You may qualify if you have a higher BMI and evidence of liver fat on imaging tests.
Chandler, ArizonaAges 18–65 - NCT07221188RecruitingPhase 3
Efimosfermin alfa for liver scarring in MASH
This study tests an investigational drug called efimosfermin alfa to see if it is safe and tolerable for people who have liver scarring (F2 or F3 stage) from a condition called MASH. The goal is to find out if the drug can help without causing serious side effects.
Arcadia, CaliforniaAges 18–75 - NCT07221227RecruitingPhase 3
Testing a new drug for MASH with moderate scarring
This trial tests a new medicine called Efimosfermin Alfa for people with MASH (a fatty liver disease) and moderate liver scarring. It aims to see if the medicine can improve the liver condition.
Chandler, ArizonaAges 18–75 - NCT05588388RecruitingPhase 2
Testing bevacizumab with chemo and immunotherapy for small cell lung cancer
This Phase 2 trial studies whether adding bevacizumab to chemo plus immunotherapy (including atezolizumab) can improve outcomes in extensive-stage small cell lung cancer (ES-SCLC) that has spread to the liver. It may help by blocking tumor blood vessel growth while boosting anti-cancer immune and treatment effects.
Los Angeles, CaliforniaAges Any age - NCT07483372RecruitingPhase 1
SC101 injection for resistant hypertension with kidney disease
This early-phase trial tests an injection called SC101 into the fat around your kidney. It aims to help lower blood pressure in people whose hypertension is poorly controlled despite multiple medications and who have moderate to severe chronic kidney disease.
Suzhou, JiangsuAges 18–65 - NCT06632444RecruitingPhase 3
Study of survodutide for liver disease NASH/MASH with fibrosis
This trial tests an investigational drug called survodutide for people with NASH or MASH, a type of fatty liver disease that also has liver scarring (moderate or advanced fibrosis). The goal is to see if the drug can improve the condition.
Birmingham, AlabamaAges 18 years+ - NCT07207057RecruitingPhase 3
Platform trial testing multiple drugs for Parkinson's disease
This trial tests several experimental drugs at once to find new treatments for Parkinson's disease. If you have Parkinson's and take medication, you may be able to join and help speed up research.
LondonAges 30 years+
Hear when a new End Stage Liver DIsease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for end stage liver disease?
- Yes. Clin2 currently lists 83 recruiting end stage liver disease studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a end stage liver disease trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a end stage liver disease trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.